JPMorgan Chase & Co. (NYSE:JPM) reported record profits for its Q3, with increased revenue in every business line. Key drivers of the results were new mortgages and refinancings, but performance continued to be strong in commercial lending, investment banking, credit cards, and auto loans.
Wells Fargo & Company (NYSE:WFC): Loans that are 90 days or more past due and still accruing with repayments insured by the Federal Housing Administration or predominantly guaranteed by the Department of Veterans Affairs for mortgages and the U.S. Department of Education for student loans under the Federal Family Education Loan Program were at $21.4 billion on September 30, 2012, which has fallen a bit from the $21.5 billion on June 30, 2012.
Are these stocks a buy or sell? Let us help you decide. Check out our Wall St. Cheat Sheet Stock Picker Newsletter now >>
NPS Pharmaceuticals, Inc. (NASDAQ:NPSP): Ahead of its meeting on October 16, the FDA’s Advisory Committee stated in briefing documents, “Our preliminary findings regarding the primary efficacy data analyses and the identification of significant safety events of interest are in general agreement with those of NPS Pharmaceuticals.” The meeting will be to discuss the safety and efficacy of the use of NPS Pharmaceuticals’ Gattex to treat adult patients with Short Bowel Syndrome for the improvement of intestinal absorption of fluid and nutrients. NPS Pharmaceuticals shares are rallying 13 percent, or $1.21, to $10.34 during pre-market trading.
Travelzoo Inc. (NASDAQ:TZOO): “We continue to be positive about our long-term growth strategy,” stated CEO Chris Loughlin, “but we have found our hotel search offering and the group-buying voucher model not meeting the needs of hotels and users well enough, and therefore plan to adjust our product offering.”
Infosys Technologies Ltd. (NASDAQ:INFY) stated in its earnings press release, “Global economic uncertainties continue to face the industry. We have increased employee wages, used some of our cash in a transformational acquisition of a consulting business and enhanced our investment in R&D and solutions. These initiatives will position us well in the industry and provide a strong platform for future growth.” Some of the company’s peers are Wipro (NYSE:WIT) and Cognizant (NASDAQ:CTSH).
Don’t Miss: LinkedIn Names 100 Most Desirable Companies.